On Remand From En Banc Court, Federal Circuit Panel Affirms Noninfringement Ruling
Mealey's (February 7, 2018, 11:43 AM EST) -- WASHINGTON, D.C. — In a Feb. 6 decision, the Federal Circuit U.S. Court of Appeals agreed with a Delaware federal judge that two patents relating to the injectable bivalirudin drug Angiomax...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login